Inventor · disambiguated record
Ulrich Reineke
Also filed as: REINEKE ULRICH
25 granted patents·8 pending applications·93 citations·filing 2005–2022
95Inventor score
Files with3B PHARMACEUTICALS GMBH9Baxalta GmbH5SHIRE ORPHAN THERAPIES GMBH5BAXTER INT3DOCKAL MICHAEL2
Top patents by PatentIndex Score
33 records- 0196US10800816B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2017·Granted Oct 13, 2020·10 cites·25 claims
- 0294US8450275B2TFPI inhibitors and methods of useDOCKAL MICHAEL·Filed 2011·Granted May 28, 2013·13 cites·31 claims
- 0393US10201586B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2016·Granted Feb 12, 2019·10 cites·17 claims
- 0488US8466108B2TFPI inhibitors and methods of useDOCKAL MICHAEL·Filed 2009·Granted Jun 18, 2013·10 cites·5 claims
- 0582US11001613B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2017·Granted May 11, 2021·1 cites·33 claims
- 0681US9745344B2NPR-B agonistsSHIRE ORPHAN THERAPIES GMBH·Filed 2015·Granted Aug 29, 2017·3 cites·8 claims
- 0781US9018167B2TFPI inhibitors and methods of useBAXTER INT·Filed 2013·Granted Apr 28, 2015·3 cites·16 claims
- 0880US10961199B2Neurotensin receptor ligands3B PHARMACEUTICALS GMBH·Filed 2013·Granted Mar 30, 2021·3 cites·26 claims
- 0980US9169293B2NPR-B agonistsSHIRE ORPHAN THERAPIES GMBH·Filed 2013·Granted Oct 27, 2015·4 cites·19 claims
- 1080US8546523B2NPR-B agonistsOSTERKAMP FRANK·Filed 2010·Granted Oct 1, 2013·7 cites·3 claims
- 1180US8071810B2C5a receptor antagonistsSCHNATBAUM KARSTEN·Filed 2006·Granted Dec 6, 2011·11 cites·18 claims
- 1279US10799605B2Conjugate comprising a neurotensin receptor ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2015·Granted Oct 13, 2020·3 cites·36 claims
- 1379US9458198B1Cyclic peptide-based NPR-B agonistsSHIRE ORPHAN THERAPIES GMBH·Filed 2013·Granted Oct 4, 2016·2 cites·20 claims
- 1478US8962563B2TFPI inhibitors and methods of useBAXTER INT·Filed 2013·Granted Feb 24, 2015·3 cites·21 claims
- 1576US9556230B2TFPI inhibitors and methods of useBAXTER INT·Filed 2015·Granted Jan 31, 2017·1 cites·10 claims
- 1674US11793855B2TFPI inhibitors and methods of useTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 24, 2023·0 cites·22 claims
- 1774US9982016B2NPR-B agonistsSHIRE ORPHAN THERAPIES GMBH·Filed 2017·Granted May 29, 2018·1 cites·10 claims
- 1872US9873720B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2014·Granted Jan 23, 2018·1 cites·4 claims
- 1972US9777051B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2013·Granted Oct 3, 2017·1 cites·10 claims
- 2069US8927534B2Compounds for the inhibition of integrins and use thereofZISCHINSKY GUNTHER·Filed 2007·Granted Jan 6, 2015·3 cites·4 claims
- 2167US8309735B2Heterocyclic compounds for the inhibition of integrins and use thereofZISCHINSKY GUNTHER·Filed 2007·Granted Nov 13, 2012·2 cites·74 claims
- 2262US10196423B2NPR-B agonistsSHIRE ORPHAN THERAPIES GMBH·Filed 2018·Granted Feb 5, 2019·0 cites·3 claims
- 2361US8410134B28-oxy-quinoline derivatives as bradykinin B2 receptor modulatorsGIBSON CHRISTOPH·Filed 2008·Granted Apr 2, 2013·1 cites·36 claims
- 2460US2021087149A1Neurotensin receptor ligands3B PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
- 2556US12427210B2Compounds comprising a fibroblast activation protein ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2020·Granted Sep 30, 2025·0 cites·55 claims
- 2654US2025296971A1Gastric inhibitory peptide receptor ligands3B PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 2754US2024115745A1Compounds comprising a fibroblast activation protein ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 2854US2025339569A1Carbonic anhydrase ix ligands3B PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 2951US2024335569A1Fibroblast activation protein inhibitors and use thereof3 B Pharmaceuticals GmbH·Filed 2022·Application pending·0 cites
- 3050US2023212549A1Compounds comprising a fibroblast activation protein ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 3144US2022315554A1Compounds comprising a fibroblast activation protein ligand and use thereof3B PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
- 3244US2008221039A1Kinin Antagonists For Treating Bladder DysfunctionGIBSON CHRISTOPH·Filed 2006·Application pending·0 cites
- 3333US8501787B2Compounds for the inhibition of angiogenesis and use thereofZAHN GRIT·Filed 2005·Granted Aug 6, 2013·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Ulrich Reineke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →